![Rafal Goraczniak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rafal Goraczniak
Fondatore presso Ceptur Therapeutics, Inc.
Posizioni attive di Rafal Goraczniak
Società | Posizione | Inizio | Fine |
---|---|---|---|
Silagene, Inc.
![]() Silagene, Inc. Medical/Nursing ServicesHealth Services Silagene, Inc. provides health care services. The company is headquartered in Hillsborough, NJ. | Direttore/Membro del Consiglio | - | - |
Ceptur Therapeutics, Inc.
![]() Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Fondatore | - | - |
Corporate Officer/Principal | - | - |
Storia della carriera di Rafal Goraczniak
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Posizioni
Director/Board Member | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Silagene, Inc.
![]() Silagene, Inc. Medical/Nursing ServicesHealth Services Silagene, Inc. provides health care services. The company is headquartered in Hillsborough, NJ. | Health Services |
Ceptur Therapeutics, Inc.
![]() Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Rafal Goraczniak
- Esperienza